Efficacy of a stannous fluoride dentifrice for relieving dentinal hypersensitivity in Chinese population: an 8-week randomized clinical trial

Objectives To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population. Materials and methods This was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-gro...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical oral investigations Ročník 28; číslo 4; s. 230
Hlavní autoři:	Li, Rui, Yang, Wenjie, Grimaldi, Roberta, Zeng, Peter, Smith, Gary, Chen, Xi
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Berlin/Heidelberg Springer Berlin Heidelberg 26.03.2024 Springer Nature B.V
Témata:	China Clinical trials Dental care Dentifrices Dentifrices - therapeutic use Dentin Desensitizing Agents - therapeutic use Dentin Sensitivity - drug therapy Dentistry Double-Blind Method Fluorides Humans Hypersensitivity Medicine Oral hygiene Phosphates - therapeutic use Placebo effect Placebos Quality of Life Side effects Sodium Fluoride - therapeutic use Stannous fluoride Statistical analysis Tin Fluorides Touch Treatment Outcome China Dentifrice Stannous fluoride Tactile threshold Dentinal hypersensitivity Placebo effect Schiff sensitivity score
ISSN:	1436-3771, 1432-6981, 1436-3771
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Objectives To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population. Materials and methods This was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)—using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)—using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)—using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL). Results Statistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related. Conclusions All groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices. Clinical relevance This study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies. Trial registration: ClinicalTrials.gov Identifier: NCT04950465.
AbstractList	To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population. This was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)-using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)-using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)-using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL). Statistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related. All groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices. This study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies. ClinicalTrials.gov Identifier: NCT04950465. ObjectivesTo compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population.Materials and methodsThis was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)—using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)—using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)—using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL).ResultsStatistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related.ConclusionsAll groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices.Clinical relevanceThis study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies.Trial registration: ClinicalTrials.gov Identifier: NCT04950465. To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population.OBJECTIVESTo compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population.This was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)-using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)-using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)-using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL).MATERIALS AND METHODSThis was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)-using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)-using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)-using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL).Statistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related.RESULTSStatistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related.All groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices.CONCLUSIONSAll groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices.This study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies.CLINICAL RELEVANCEThis study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies.ClinicalTrials.gov Identifier: NCT04950465.TRIAL REGISTRATIONClinicalTrials.gov Identifier: NCT04950465. Objectives To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese population. Materials and methods This was a single-centre, randomized, controlled, examiner-blind, three-treatment-arm, parallel-group study in participants with clinically diagnosed DH. Subjects who met inclusion criteria (n = 197) were randomly allocated into 3 groups: test group (n = 66)—using a 0.454% stannous fluoride-containing dentifrice twice daily; positive control group (n = 64)—using a 5.0% calcium sodium phosphosilicate-containing dentifrice twice daily; negative control group (n = 67)—using a 1150 ppm of NaF dentifrice twice daily. Status of DH was assessed at week 4 and week 8 by the same independent examiner. Changes from baseline in Schiff sensitivity score, tactile threshold and Dentine Hypersensitivity Experience Questionnaire (DHEQ) score were analysed using analysis of covariance models. The DHEQ evaluated subject-perceived oral health-related quality of life (OHRQoL). Results Statistically significant improvements in mean Schiff scores (p < 0.0001 for all products at Weeks 4 and 8), tactile threshold (p < 0.0001 for test and negative control at Weeks 4 and 8: Week 4 p = 0.0040 and Week 8 p < 0.0001 for positive control) and all DHEQ scores (p < 0.01 for all groups) were observed. No statistically significant differences were observed in the adjusted mean between all dentifrices at both timepoints, potentially driven by a placebo effect. Forty-two treatment-emergent adverse events (TEAEs) were reported (n = 32 subjects), with 2 serious AEs (n = 1) in the test group. TEAEs were not considered treatment-related. Conclusions All groups demonstrated statistically significant improvements in Schiff score, tactile threshold and OHRQoL. However, due to a possible placebo effect in the negative control, there were no statistically significant differences between the dentifrices. Clinical relevance This study adds to the growing research exploring why the placebo effect is a common phenomenon in DH studies. Trial registration: ClinicalTrials.gov Identifier: NCT04950465.
ArticleNumber	230
Author	Zeng, Peter Chen, Xi Grimaldi, Roberta Yang, Wenjie Smith, Gary Li, Rui
Author_xml	– sequence: 1 givenname: Rui surname: Li fullname: Li, Rui organization: Department of Preventive Dentistry, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology – sequence: 2 givenname: Wenjie surname: Yang fullname: Yang, Wenjie organization: Department of Preventive Dentistry, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology – sequence: 3 givenname: Roberta surname: Grimaldi fullname: Grimaldi, Roberta organization: Haleon (Formerly Known As GSK Consumer Healthcare) – sequence: 4 givenname: Peter surname: Zeng fullname: Zeng, Peter organization: Haleon (Formerly Known As GSK Consumer Healthcare) – sequence: 5 givenname: Gary surname: Smith fullname: Smith, Gary organization: Haleon (Formerly Known As GSK Consumer Healthcare) – sequence: 6 givenname: Xi surname: Chen fullname: Chen, Xi email: chenx1853@sh9hospital.org.cn organization: Department of Preventive Dentistry, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38530474$$D View this record in MEDLINE/PubMed
BookMark	eNp9UsluFDEUtFAQWeAHOCBLXLg0eOm221wQGoVFisQFzpbb_Tzj4LEHu3vQ8A_8M046hJBDDl6kV1Vvq1N0FFMEhJ5T8poSIt-UevVtQ1g9naCkUY_QCW25aLiU9OjO_xidlnJJCG2F5E_QMe87TlrZnqDf5855a-wBJ4cNLpOJMc0FuzCn7EfAI8TJu-wtYJcyzhA87H1cL4FoAt4cdpALxOInv_fTAfuIVxsfoQDepd0czORTfItNxH3zE-A7ziaOaet_wYht8LHmD3jK3oSn6LEzocCzm_cMfftw_nX1qbn48vHz6v1FY1vZTY3gfBhNyxhTxqnBdKIfht4qp5ywbAAyuE44aTsxMso5tVJwRscBmATW2YGfoXeL7m4etjDa2ko2Qe-y35p80Ml4_X8k-o1ep72mRIlOUlEVXt0o5PRjhjLprS8WQjAR6vw0J4S3XPVKVejLe9DLNOc6uaKZ6oVkXFFZUS_ulnRby99VVQBbADanUjK4Wwgl-soPevGDrn7Q137QV7n7eyTrp-t91LZ8eJjKF2qpeeIa8r-yH2D9AcBlzXk
CitedBy_id	crossref_primary_10_1186_s12903_025_06288_5 crossref_primary_10_1186_s12903_024_05235_0 crossref_primary_10_1007_s00784_025_06155_1 crossref_primary_10_3390_jfb16030073
Cites_doi	10.5005/jcdp-6-2-107 10.1007/s00784-012-0911-1 10.1007/s11136-014-0856-8 10.1111/j.1600-051x.1978.tb02279.x 10.1007/s00784-012-0891-1 10.4103/0972-0707.73385 10.1111/jcpe 10.1111/j.1600-051X.2010.01618.x 10.1016/S0099-2399(86)80201-1 10.1111/j.1600-051x.1997.tb01833.x 10.1016/j.jdent.2017.02.009 10.1080/00016357.2017.1323348 10.1111/j.1600-051x.1997.tb01194.x 10.1111/j.1600-0722.2012.00962.x 10.5005/jcdp-2-1-27 10.1007/s00784-012-0888-9 10.4103/jisp.jisp_233_22 10.1177/10454411960070020101 10.4103/2231-0762.115700 10.1111/jcpe.12175 10.1016/j.jdent.2018.12.015 10.18502/fid.v16i5.2272 10.1016/B978-0-12-801631-2.00009-9 10.1186/s12903-019-0919-x
ContentType	Journal Article
Copyright	The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1007/s00784-024-05610-9
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE ProQuest Central Student MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Dentistry
EISSN	1436-3771
ExternalDocumentID	PMC10965716 38530474 10_1007_s00784_024_05610_9
Genre	Randomized Controlled Trial Journal Article
GeographicLocations	China
GeographicLocations_xml	– name: China
GroupedDBID	--- -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29B 29~ 2J2 2JN 2JY 2KG 2LR 2~H 30V 34H 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 78A 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BENPR BGNMA BHPHI BSONS C6C CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI ESBYG F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ I09 IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Y I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P2P P9S PF0 PT4 PT5 QOR QOS R89 R9I RNS ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7V Z7W Z7X Z81 Z82 Z83 Z87 ZMTXR ZOVNA 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ABUWG ACSTC AEZWR AFDZB AFFHD AFHIU AFKRA AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA BBNVY BPHCQ BVXVI CCPQU CITATION EBD FYUFA HMCUK LK8 M1P M7P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X UKHRP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c475t-633bda42229af9ba568bb8c9f9f6c2be0bf56f7c56d21331c76321dbe27e25cb3
IEDL.DBID	RSV
ISICitedReferencesCount	4
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001191330000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1436-3771 1432-6981
IngestDate	Tue Nov 04 02:05:55 EST 2025 Sun Nov 09 13:17:12 EST 2025 Tue Nov 25 13:31:02 EST 2025 Wed Feb 19 02:03:44 EST 2025 Sat Nov 29 02:19:10 EST 2025 Tue Nov 18 22:16:35 EST 2025 Fri Feb 21 02:42:07 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	Dentifrice Stannous fluoride Tactile threshold Dentinal hypersensitivity Placebo effect Schiff sensitivity score
Language	English
License	2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c475t-633bda42229af9ba568bb8c9f9f6c2be0bf56f7c56d21331c76321dbe27e25cb3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23
OpenAccessLink	https://link.springer.com/10.1007/s00784-024-05610-9
PMID	38530474
PQID	2986723917
PQPubID	33690
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_10965716 proquest_miscellaneous_3003439899 proquest_journals_2986723917 pubmed_primary_38530474 crossref_primary_10_1007_s00784_024_05610_9 crossref_citationtrail_10_1007_s00784_024_05610_9 springer_journals_10_1007_s00784_024_05610_9
PublicationCentury	2000
PublicationDate	2024-03-26
PublicationDateYYYYMMDD	2024-03-26
PublicationDate_xml	– month: 03 year: 2024 text: 2024-03-26 day: 26
PublicationDecade	2020
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany – name: Heidelberg
PublicationTitle	Clinical oral investigations
PublicationTitleAbbrev	Clin Oral Invest
PublicationTitleAlternate	Clin Oral Investig
PublicationYear	2024
Publisher	Springer Berlin Heidelberg Springer Nature B.V
Publisher_xml	– name: Springer Berlin Heidelberg – name: Springer Nature B.V
References	He, Wang (CR29) 2015; 24 van der Velden, de Vries (CR34) 1978; 5 Ni, He, Chang, Sun (CR38) 2010; 23 Zeola, Soares, Cunha-Cruz (CR1) 2019; 81 Pashley (CR6) 1996; 7 CR19 Liang, Wei, Hu, Ruan (CR37) 2017; 75 Tao, Ling, Feng, Gallob, Souverain, Yang, Alavi (CR18) 2020; 47 Hall, Mason, Cooke (CR30) 2017; 60 CR17 CR16 Idon, Esan, Bamise (CR22) 2017; 6 Makin (CR39) 2013; 26 Brännström, Anderson (CR4) 1963 CR33 Walters (CR9) 2005; 6 Gibson, Boiko, Baker, Robinson, Barlow, Player, Robinson (CR20) 2010 Gillam (CR21) 2021; 4 Gillam (CR36) 2013; 17 Davari, Ataei, Assarzadeh (CR2) 2013; 14 Jacobsen, Bruce (CR8) 2001; 2 Pashley (CR10) 1986; 12 Grover, Kumar, Jain (CR11) 2022; 26 He, Chang, Cheng, Li, Sun, Biesbrock (CR14) 2011; 24 West, Addy, Jackson, Ridge (CR42) 1997; 24 CR27 He, Cheng, Biesbrock, Chang, Sun (CR15) 2011; 22 CR25 Miglani, Aggarwal, Ahuja (CR12) 2010; 13 Cartwright (CR7) 2014; 31 Bekes, Hirsch (CR23) 2013; 17 Boiko, Baker, Gibson, Locker, Sufi, Barlow, Robinson (CR26) 2010; 37 Holland, Narhi, Addy, Gangarosa, Orchardson (CR32) 1997; 24 Orchardson, Gillam (CR3) 2000; 14 Bennadi, Reddy (CR24) 2013; 3 CR40 Machuca, Baker, Sufi, Mason, Barlow, Robinson (CR28) 2013; 41 Schiff, Dotson, Cohen, De Vizio, McCool, Volpe (CR35) 1994; 5 He, Wang, Wang (CR43) 2012; 120 Hall, Embery, Shellis, Addy, Embery, Edgar, Orchardson (CR5) 2000 Du, Bian, Jiang, Greenspan, Burwell, Zhong, Tai (CR31) 2008; 21 He, Barker, Qaqish, Sharma (CR13) 2011; 22 Gernhardt (CR41) 2013; 17 T He (5610_CR14) 2011; 24 W Liang (5610_CR37) 2017; 75 5610_CR19 DG Gillam (5610_CR21) 2021; 4 K Bekes (5610_CR23) 2013; 17 5610_CR17 PI Idon (5610_CR22) 2017; 6 D Bennadi (5610_CR24) 2013; 3 5610_CR16 5610_CR33 LX Ni (5610_CR38) 2010; 23 V Grover (5610_CR11) 2022; 26 CR Gernhardt (5610_CR41) 2013; 17 NX West (5610_CR42) 1997; 24 AR Davari (5610_CR2) 2013; 14 BJ Gibson (5610_CR20) 2010 G Holland (5610_CR32) 1997; 24 OV Boiko (5610_CR26) 2010; 37 R Hall (5610_CR5) 2000 S Miglani (5610_CR12) 2010; 13 M Du (5610_CR31) 2008; 21 C Machuca (5610_CR28) 2013; 41 U van der Velden (5610_CR34) 1978; 5 P Walters (5610_CR9) 2005; 6 FL Zeola (5610_CR1) 2019; 81 M Brännström (5610_CR4) 1963 C Hall (5610_CR30) 2017; 60 DH Pashley (5610_CR10) 1986; 12 T He (5610_CR15) 2011; 22 R Cartwright (5610_CR7) 2014; 31 SL He (5610_CR29) 2015; 24 P Jacobsen (5610_CR8) 2001; 2 DG Gillam (5610_CR36) 2013; 17 S Makin (5610_CR39) 2013; 26 SL He (5610_CR43) 2012; 120 T He (5610_CR13) 2011; 22 5610_CR27 5610_CR25 5610_CR40 DH Pashley (5610_CR6) 1996; 7 T Schiff (5610_CR35) 1994; 5 R Orchardson (5610_CR3) 2000; 14 D Tao (5610_CR18) 2020; 47
References_xml	– volume: 23 start-page: 17B year: 2010 end-page: 21B ident: CR38 article-title: The desensitizing efficacy of a novel stannous-containing sodium fluoride dentifrice: an 8-week randomized and controlled clinical trial publication-title: Am J Dent – volume: 6 start-page: 1017 year: 2005 end-page: 1117 ident: CR9 article-title: Dentinal hypersensitivity: a review publication-title: J Contemp Dent Pract doi: 10.5005/jcdp-6-2-107 – volume: 24 start-page: 336 year: 2011 end-page: 340 ident: CR14 article-title: Clinical evaluation of the fast onset and sustained sensitivity relief of a 0.454% stannous fluoride dentifrice compared to an 8.0% arginine-calcium carbonate-sodium monofluorophosphate dentifrice publication-title: Am J Dent – volume: 17 start-page: S21 year: 2013 end-page: S29 ident: CR36 article-title: Current diagnosis of dentin hypersensitivityin the dental office: an overview publication-title: Clin Oral Invest doi: 10.1007/s00784-012-0911-1 – ident: CR16 – start-page: 3 year: 2000 end-page: 19 ident: CR5 article-title: Biological and structural features of enamel and dentin: current concepts relevant to erosion and dentin hypersensitivity publication-title: Tooth wear and sensitivity – volume: 22 start-page: 46 year: 2011 end-page: 50 ident: CR13 article-title: Fast onset sensitivity relief of a 0.454% stannous fluoride dentifrice publication-title: J Clin Dent – volume: 24 start-page: 1465 year: 2015 end-page: 1469 ident: CR29 article-title: Reliability and validity of the Chinese version of the short form of the Dentine Hypersensitivity Experience Questionnaire (DHEQ-15) publication-title: Qual Life Res doi: 10.1007/s11136-014-0856-8 – ident: CR33 – volume: 5 start-page: 188 year: 1978 end-page: 197 ident: CR34 article-title: Introduction of a new periodontal probe: the pressure probe publication-title: J Clin Periodontol doi: 10.1111/j.1600-051x.1978.tb02279.x – volume: 17 start-page: 31 year: 2013 end-page: 40 ident: CR41 article-title: How valid and applicable are current diagnostic criteria and assessment methods for dentin hypersensitivity? An overview publication-title: Clin Oral Invest doi: 10.1007/s00784-012-0891-1 – volume: 13 start-page: 218 year: 2010 end-page: 224 ident: CR12 article-title: Dentin hypersensitivity: recent trends in management publication-title: J Conservt Dent doi: 10.4103/0972-0707.73385 – volume: 47 start-page: 962 year: 2020 end-page: 969 ident: CR18 article-title: Efficacy of an anhydrous stannous fluoride toothpaste for relief of dentine hypersensitivity: a randomized clinical study publication-title: J Clinic Periodontol doi: 10.1111/jcpe – volume: 22 start-page: 40 year: 2011 end-page: 45 ident: CR15 article-title: Rapid desensitizing efficacy of a stannous-containing sodium fluoride dentifrice publication-title: J Clin Dent – volume: 37 start-page: 973 year: 2010 end-page: 980 ident: CR26 article-title: Construction and validation of the quality of life measure for dentine hypersensitivity (DHEQ) publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.2010.01618.x – volume: 6 start-page: 99 year: 2017 end-page: 105 ident: CR22 article-title: Oral health-related quality of life in patients presenting with dentine hypersensitivity: a randomized controlled study of treatment effect publication-title: Eur J Gen Dent – volume: 26 start-page: 3A year: 2013 end-page: 9A ident: CR39 article-title: Stannous fluoride dentifrices publication-title: Am J Dent – volume: 12 start-page: 465 year: 1986 end-page: 474 ident: CR10 article-title: Dentin permeability, dentin sensitivity, and treatment through tubule occlusion publication-title: J Endod doi: 10.1016/S0099-2399(86)80201-1 – start-page: 89 year: 2010 end-page: 107 ident: CR20 article-title: The everyday impact of dentine sensitivity: personal and functional aspects publication-title: Dentine hypersensitivity – volume: 4 start-page: 1 year: 2021 end-page: 6 ident: CR21 article-title: The impact of dentine hypersensitivity on the quality of life: an overview publication-title: Clin Oral Sci Dent – ident: CR40 – ident: CR25 – volume: 24 start-page: 209 year: 1997 end-page: 215 ident: CR42 article-title: Dentine hypersensitivity and the placebo response. A comparison of the effect of strontium acetate, potassium nitrate and fluoride toothpastes publication-title: J Clinic Periodontol doi: 10.1111/j.1600-051x.1997.tb01833.x – ident: CR27 – volume: 31 start-page: 15 year: 2014 end-page: 20 ident: CR7 article-title: Dentinal hypersensitivity: a narrative review publication-title: Community Dent Health – volume: 5 start-page: 87 year: 1994 end-page: 92 ident: CR35 article-title: Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study publication-title: J Clin Dent – volume: 14 start-page: 136 year: 2013 end-page: 145 ident: CR2 article-title: Dentin hypersensitivity: etiology, diagnosis and treatment; a literature review publication-title: J Dent (Shiraz) – ident: CR19 – start-page: 73 year: 1963 end-page: 79 ident: CR4 article-title: A hydrodynamic mechanism in the transmission of pain producing stimuli through dentin publication-title: Sensory mechanisms in dentin – volume: 60 start-page: 36 year: 2017 end-page: 43 ident: CR30 article-title: Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes – a 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste – for the longer-term relief of dentine hypersensitivity publication-title: J Dent doi: 10.1016/j.jdent.2017.02.009 – volume: 75 start-page: 387 year: 2017 end-page: 393 ident: CR37 article-title: Prevalence of dentin hypersensitivity among the residents of Xi’an city, China publication-title: Acta Ondontol Scand doi: 10.1080/00016357.2017.1323348 – volume: 24 start-page: 808 year: 1997 end-page: 813 ident: CR32 article-title: Guidelines for the design and conduct of clinical trials on dentine hypersensitivity publication-title: J Clin Peridontol doi: 10.1111/j.1600-051x.1997.tb01194.x – volume: 120 start-page: 218 year: 2012 end-page: 223 ident: CR43 article-title: Development of the Chinese version of the dentine hypersensitivity experience questionnaire publication-title: Eur J Oral Sci doi: 10.1111/j.1600-0722.2012.00962.x – volume: 2 start-page: 1 year: 2001 end-page: 12 ident: CR8 article-title: Clinical dentin hypersensitivity: Understanding the causes and prescribing a treatment publication-title: J Contemp Dent Pract doi: 10.5005/jcdp-2-1-27 – ident: CR17 – volume: 21 start-page: 210 year: 2008 end-page: 214 ident: CR31 article-title: Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (novamin) for the treatment of dentin hypersensitivity publication-title: Am J Dent – volume: 17 start-page: 45 year: 2013 end-page: 51 ident: CR23 article-title: What is known about the influence of dentine hypersensitivity on oral health-related quality of life? publication-title: Clin Oral Investig doi: 10.1007/s00784-012-0888-9 – volume: 26 start-page: 307 year: 2022 end-page: 333 ident: CR11 article-title: ISP good clinical practice recommendations for the management of dentin hypersensitivity publication-title: J Indian Soc Periodontol doi: 10.4103/jisp.jisp_233_22 – volume: 7 start-page: 104 year: 1996 end-page: 133 ident: CR6 article-title: Dynamics of the pulpo-dentin complex publication-title: Crit Rev Oral Biol Med doi: 10.1177/10454411960070020101 – volume: 14 start-page: 9 year: 2000 end-page: 19 ident: CR3 article-title: The efficacy of potassium salts as agents for treating dentin hypersensitivity publication-title: J Orofac Pain – volume: 3 start-page: 1 year: 2013 end-page: 6 ident: CR24 article-title: Oral health related quality of life publication-title: J Int Soc Prevent Community Dent doi: 10.4103/2231-0762.115700 – volume: 41 start-page: 46 year: 2013 end-page: 51 ident: CR28 article-title: Derivation of a short form of the dentine hypersensitivity experience questionnaire publication-title: J Clin Periodontol doi: 10.1111/jcpe.12175 – volume: 81 start-page: 1 year: 2019 end-page: 6 ident: CR1 article-title: Prevalence of dentin hypersensitivity: systematic review and meta-analysis publication-title: J Dent doi: 10.1016/j.jdent.2018.12.015 – volume: 5 start-page: 188 year: 1978 ident: 5610_CR34 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051x.1978.tb02279.x – volume: 21 start-page: 210 year: 2008 ident: 5610_CR31 publication-title: Am J Dent – ident: 5610_CR27 – volume: 13 start-page: 218 year: 2010 ident: 5610_CR12 publication-title: J Conservt Dent doi: 10.4103/0972-0707.73385 – ident: 5610_CR40 doi: 10.18502/fid.v16i5.2272 – volume: 31 start-page: 15 year: 2014 ident: 5610_CR7 publication-title: Community Dent Health – volume: 47 start-page: 962 year: 2020 ident: 5610_CR18 publication-title: J Clinic Periodontol doi: 10.1111/jcpe – volume: 17 start-page: 31 year: 2013 ident: 5610_CR41 publication-title: Clin Oral Invest doi: 10.1007/s00784-012-0891-1 – volume: 120 start-page: 218 year: 2012 ident: 5610_CR43 publication-title: Eur J Oral Sci doi: 10.1111/j.1600-0722.2012.00962.x – ident: 5610_CR25 doi: 10.1016/B978-0-12-801631-2.00009-9 – start-page: 3 volume-title: Tooth wear and sensitivity year: 2000 ident: 5610_CR5 – ident: 5610_CR16 – ident: 5610_CR33 – volume: 22 start-page: 46 year: 2011 ident: 5610_CR13 publication-title: J Clin Dent – start-page: 89 volume-title: Dentine hypersensitivity year: 2010 ident: 5610_CR20 – volume: 5 start-page: 87 year: 1994 ident: 5610_CR35 publication-title: J Clin Dent – volume: 6 start-page: 99 year: 2017 ident: 5610_CR22 publication-title: Eur J Gen Dent – volume: 26 start-page: 3A year: 2013 ident: 5610_CR39 publication-title: Am J Dent – volume: 81 start-page: 1 year: 2019 ident: 5610_CR1 publication-title: J Dent doi: 10.1016/j.jdent.2018.12.015 – volume: 26 start-page: 307 year: 2022 ident: 5610_CR11 publication-title: J Indian Soc Periodontol doi: 10.4103/jisp.jisp_233_22 – volume: 3 start-page: 1 year: 2013 ident: 5610_CR24 publication-title: J Int Soc Prevent Community Dent doi: 10.4103/2231-0762.115700 – volume: 60 start-page: 36 year: 2017 ident: 5610_CR30 publication-title: J Dent doi: 10.1016/j.jdent.2017.02.009 – volume: 22 start-page: 40 year: 2011 ident: 5610_CR15 publication-title: J Clin Dent – volume: 23 start-page: 17B year: 2010 ident: 5610_CR38 publication-title: Am J Dent – volume: 24 start-page: 336 year: 2011 ident: 5610_CR14 publication-title: Am J Dent – volume: 4 start-page: 1 year: 2021 ident: 5610_CR21 publication-title: Clin Oral Sci Dent – volume: 24 start-page: 1465 year: 2015 ident: 5610_CR29 publication-title: Qual Life Res doi: 10.1007/s11136-014-0856-8 – volume: 7 start-page: 104 year: 1996 ident: 5610_CR6 publication-title: Crit Rev Oral Biol Med doi: 10.1177/10454411960070020101 – volume: 17 start-page: 45 year: 2013 ident: 5610_CR23 publication-title: Clin Oral Investig doi: 10.1007/s00784-012-0888-9 – volume: 24 start-page: 209 year: 1997 ident: 5610_CR42 publication-title: J Clinic Periodontol doi: 10.1111/j.1600-051x.1997.tb01833.x – volume: 6 start-page: 1017 year: 2005 ident: 5610_CR9 publication-title: J Contemp Dent Pract doi: 10.5005/jcdp-6-2-107 – start-page: 73 volume-title: Sensory mechanisms in dentin year: 1963 ident: 5610_CR4 – volume: 2 start-page: 1 year: 2001 ident: 5610_CR8 publication-title: J Contemp Dent Pract doi: 10.5005/jcdp-2-1-27 – volume: 14 start-page: 9 year: 2000 ident: 5610_CR3 publication-title: J Orofac Pain – volume: 17 start-page: S21 year: 2013 ident: 5610_CR36 publication-title: Clin Oral Invest doi: 10.1007/s00784-012-0911-1 – volume: 37 start-page: 973 year: 2010 ident: 5610_CR26 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.2010.01618.x – volume: 14 start-page: 136 year: 2013 ident: 5610_CR2 publication-title: J Dent (Shiraz) – volume: 12 start-page: 465 year: 1986 ident: 5610_CR10 publication-title: J Endod doi: 10.1016/S0099-2399(86)80201-1 – ident: 5610_CR17 – volume: 41 start-page: 46 year: 2013 ident: 5610_CR28 publication-title: J Clin Periodontol doi: 10.1111/jcpe.12175 – volume: 75 start-page: 387 year: 2017 ident: 5610_CR37 publication-title: Acta Ondontol Scand doi: 10.1080/00016357.2017.1323348 – volume: 24 start-page: 808 year: 1997 ident: 5610_CR32 publication-title: J Clin Peridontol doi: 10.1111/j.1600-051x.1997.tb01194.x – ident: 5610_CR19 doi: 10.1186/s12903-019-0919-x
SSID	ssj0014673
Score	2.4025548
Snippet	Objectives To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a... To compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a Chinese... ObjectivesTo compare the effectiveness of using a 0.454% stannous fluoride-containing dentifrice twice daily in relieving dentinal hypersensitivity (DH) in a...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	230
SubjectTerms	China Clinical trials Dental care Dentifrices Dentifrices - therapeutic use Dentin Desensitizing Agents - therapeutic use Dentin Sensitivity - drug therapy Dentistry Double-Blind Method Fluorides Humans Hypersensitivity Medicine Oral hygiene Phosphates - therapeutic use Placebo effect Placebos Quality of Life Side effects Sodium Fluoride - therapeutic use Stannous fluoride Statistical analysis Tin Fluorides Touch Treatment Outcome
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1BQbQXPgqFQEFG4gYWGztObC4IQSsOUPUAqLco_oi6aptddlsq-A_8Z2YcJ9VS0QtnZ5O1Zux54xm_B_DC6eBUZRVXrnC8yPWE61YW3BITskdILCKV0rdP1d6ePjgw--nAbZnaKoc9MW7UfubojPy1MLqshMTs4u38OyfVKKquJgmN63CDWBJkbN3bH6sIuAnEBvtCCl4anadLM_HqHMXGgmOE4oShJ9ysBqZLaPNy0-RfldMYkHbv_O9U7sLtBEXZu9537sG10G3C-gdqHyIFuE249TkV3u_D7x2immjcTzZrWcMIUhK3K2uPz_DNPrB435c0hwJDGMwWAbEtnVX0A_SdQ8x4F0vql-8FK9i0Y6TeHZaBzUcZsTes6Zjm5yEcMQyjfnYy_RU8Gy5wsqgy8gC-7u58ef-RJyUH7opKnfJSSusbOm0yTWtso0ptrXamNW3phA0T26qyrZwqvcCkOXe464nc2yCqIJSzcgvWulkXHgELCCgsopAgrO-VsxHiylZ5UxnfNFUG-WDG2iWac1LbOK5HguZo-hpNX0fT1yaDl-Nv5j3Jx5VPbw9mrdOCX9YXNs3g-TiMS5XqL00X0CS1JDIgaTDDzeBh70zj5yTCpklRFRnoFTcbHyAa8NWRbnoY6cBzIvDBtDeDV4NHXvyvf0_j8dXTeAIbIq4OyUW5DWuni7PwFG66H-iDi2dxnf0B6pswIg priority: 102 providerName: ProQuest
Title	Efficacy of a stannous fluoride dentifrice for relieving dentinal hypersensitivity in Chinese population: an 8-week randomized clinical trial
URI	https://link.springer.com/article/10.1007/s00784-024-05610-9 https://www.ncbi.nlm.nih.gov/pubmed/38530474 https://www.proquest.com/docview/2986723917 https://www.proquest.com/docview/3003439899 https://pubmed.ncbi.nlm.nih.gov/PMC10965716
Volume	28
WOSCitedRecordID	wos001191330000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1436-3771 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014673 issn: 1436-3771 databaseCode: M7P dateStart: 20240101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1436-3771 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014673 issn: 1436-3771 databaseCode: 7X7 dateStart: 20240101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1436-3771 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014673 issn: 1436-3771 databaseCode: BENPR dateStart: 20240101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1436-3771 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014673 issn: 1436-3771 databaseCode: 8C1 dateStart: 20240101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1436-3771 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014673 issn: 1436-3771 databaseCode: RSV dateStart: 19970301 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RFgEXHuUVKCsjcQNLGzuJbW5QtuIAq1WBam9R_Ii6omSr3RYE_4H_zIzzQEsBCS652JYTZybzTWbmG4AnTgeXK5vz3GWOZ6kec13LjFtiQvYIiUWkUjp6o6ZTPZ-bWVcUtu6z3fuQZPxSD8VuZM0yjjaFE-odc7MFO2juNKnj4bujIXaAqi-78pjfr9s0QRdw5cX0yF9ipNH0HNz4v5u-Cdc7qMletLJxCy6FZheuvqL0IOrwtgtX3naB9dvwfUJUEpX7ypY1qxhBRuJuZfXJ-XK18IHFel7qKRQYwly2Cohd6V9EO0D7HKNHu1pTPnzbkIItGkbducM6sNOhTdhzVjVM8y8hfGRoJv3y0-Jb8Kwv0GSxi8gd-HAweb__mnedGrjLVH7GCymtr-hvkqlqY6u80NZqZ2pTF07YMLZ1XtTK5YUX6BSnDr9qIvU2CBVE7qy8C9vNsgn3gQUEDBZRRhDWt52xEcLKOvdGGV9VKoG0f3ml62jMqZvGSTkQMMczL_HMy3jmpUng6bDmtCXx-OvsvV4myk6h16UwulBConObwONhGFWR4itVE_CVlJLIfqRBDzaBe60IDdtJhEXjTGUJ6A3hGiYQzffmSLM4jnTfKRH0oFubwLNexn7e158f48G_TX8I10QUU8lFsQfbZ6vz8Aguu88ok6sRbKm5ileNV72fjmDn5WQ6OxxRsuxsFDXwB19wKUw
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigXHuUVKGAkOIHFxs7DRkII0Vatuq16KKi3ED-irijZZbelKv-Bv8JvZMZ5VEtFbz1wdjZZJzPjb-yZ7wN4YZW3aW5SntrE8iRWA64qmXBDTMgOIbEIVEqfh_nOjtrf17sL8LvrhaGyyi4mhkDtxpb2yN8IrbJcSMwu3k--c1KNotPVTkKjMYstf3qCKdvs3eYqft-XQqyv7X3c4K2qALdJnh7xTErjStr50GWlTZlmyhhldaWrzArjB6ZKsyq3aeYEJnCxRQ8UsTNe5F6k1ki87xW4ijBCqFAquNufWmDQCQX9iRQ80ypum3RCqx6txQnHFZETZh9wPb8QnkO354s0_zqpDQvg-q3_7dXdhpst1GYfGt-4Awu-XoalVSqPIoW7Zbi-3RYW3IVfa0SlUdpTNq5YyQgyE3ctqw6PcSbOs9DPTJpKniHMZ1OP2J32YpoBes4BZvTTGfUDNIIcbFQzUif3M88mvUzaW1bWTPET778yhAlu_G300zvWNaiyoKJyDz5dyou5D4v1uPYPgXkETAZRlhfGNcrgCOFllTqda1eWeQRxZzaFbWncSU3ksOgJqIOpFWhqRTC1Qkfwqv_NpCExufDqlc6MijagzYozG4rgeT-MoYjOl8ra4ycpJJEdSY0ZfAQPGuPtHycRFg6SPIlAzZl1fwHRnM-P1KODQHceE0ERpvURvO484Ox__Xsajy6exjNY2tjbHhbDzZ2tx3BDBM-UXGQrsHg0PfZP4Jr9gfY4fRp8nMGXy_aMP_8cjnU
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEC2FgEIuLGFzCNBIcIJWxt3eGgkhlMmIKGGUA6DcHPdiZUTwTGayKPwDP8TXUdVeoiEitxw4t8eetl9Vv-quegXwymTOxKmOeWwiw6Mw6_GslBHXpIRskRILL6X0bScdDrO9PbW7AL_bWhhKq2x9onfUdmxoj3xdqCxJhcToYr1s0iJ2-4MPkyNOHaTopLVtp1FDZNudn2H4Nnu_1cdv_VqIweaXjU-86TDATZTGxzyRUtuCdkFUUSpdxEmmdWZUqcrECO16uoyTMjVxYgUGc6FBaxSh1U6kTsRGS7zvDbiZSkQxValvdOkl5IB8cn8kBU9UFjYFO75sj9bliOPqyIm_97iaXxQvMd3LCZt_ndr6xXBw939-jffgTkPB2cfaZu7DgqtW4Haf0qao890KLH1uEg4ewK9NktgozDkbl6xgRKVJ05aVhyc4E-uYr3OmXkuOIf1nU4ecnvZo6gF6zgFG-tMZ1QnUjTrYqGLUtdzNHJt07dPesaJiGT9z7jtD-mDHP0Y_nWVt4Srz3VUewtdreTGPYLEaV-4JMIdESiP7ckLbumM4UntZxlalyhZFGkDYQig3jbw7dRk5zDthag-7HGGXe9jlKoA33W8mtbjJlVevtZDKG0c3yy_wFMDLbhhdFJ07FZXDT5JLEkGSCiP7AB7XQO4eJ5Eu9qI0CiCbg3h3Acmfz49UowMvgx6ScBGG-wG8ba3h4n_9exqrV0_jBSyhQeQ7W8Ptp7AsvJFKLpI1WDyenrhncMucIhynz725M9i_bsP4A1Pklus
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+a+stannous+fluoride+dentifrice+for+relieving+dentinal+hypersensitivity+in+Chinese+population%3A+an+8-week+randomized+clinical+trial&rft.jtitle=Clinical+oral+investigations&rft.au=Li%2C+Rui&rft.au=Yang%2C+Wenjie&rft.au=Grimaldi%2C+Roberta&rft.au=Zeng%2C+Peter&rft.date=2024-03-26&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=1436-3771&rft.volume=28&rft.issue=4&rft_id=info:doi/10.1007%2Fs00784-024-05610-9&rft.externalDocID=10_1007_s00784_024_05610_9
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1436-3771&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1436-3771&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1436-3771&client=summon